Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Palo Alto Investors is a hedge fund and venture firm founded in 1989 specializing in healthcare and life sciences investments, especially in biotechnology, medical devices, healthcare services, and digital health sectors. It is known for early-stage and innovation-driven investments in public and private companies, with a strong long-term, long-only public equity investment strategy focused on micro- and small-cap firms in the healthcare industry. The firm is currently active, managing over $1.1–$1.9 billion in assets, and has been influential in shaping emerging health technologies.[1][2][3]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Palo Alto Investors.